Literature DB >> 9682283

Organizational guidelines for dual disorders programs.

C C Mercer1, K T Mueser, R E Drake.   

Abstract

Dual disorders--combined severe mental disorders and substance use disorders--were barely recognized two decades ago. As a result of the high prevalence and serious consequences of these disorders, they have received considerable attention over the last two decades. Knowledge has accumulated about dual disorders and their treatment, and treatment providers may now consider numerous options for clinical interventions and program designs. In this article, we offer guidelines concerning these options. We review the current knowledge about dual disorders and the results of recent research on the assessment and treatment of these disorders. We present treatment principles, recommendations on the components and organization of dual disorders programs, and suggestions for dealing with clinical issues that remain controversial. We conclude with comments on the demands of the managed care environment and the heightened importance of continued research in this area.

Entities:  

Mesh:

Year:  1998        PMID: 9682283     DOI: 10.1023/a:1022145125499

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  62 in total

1.  THE MULTIPLE READMISSION PSYCHIATRIC PATIENT.

Authors:  A D POKORNY
Journal:  Psychiatr Q       Date:  1965-01

2.  Co-occurring disorders among mentally ill jail detainees. Implications for public policy.

Authors:  K M Abram; L A Teplin
Journal:  Am Psychol       Date:  1991-10

3.  Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach.

Authors:  K B Carey
Journal:  Community Ment Health J       Date:  1996-06

4.  A scale for assessing the stage of substance abuse treatment in persons with severe mental illness.

Authors:  G J McHugo; R E Drake; H L Burton; T H Ackerson
Journal:  J Nerv Ment Dis       Date:  1995-12       Impact factor: 2.254

5.  Consumers as service providers: the promise and challenge.

Authors:  L Dixon; N Krauss; A Lehman
Journal:  Community Ment Health J       Date:  1994-12

6.  Recent psychostimulant use in hospitalized schizophrenics.

Authors:  M L Richard; B I Liskow; P J Perry
Journal:  J Clin Psychiatry       Date:  1985-03       Impact factor: 4.384

7.  Alcohol use and abuse in schizophrenia. A prospective community study.

Authors:  R E Drake; F C Osher; M A Wallach
Journal:  J Nerv Ment Dis       Date:  1989-07       Impact factor: 2.254

8.  The young adult chronic patient: overview of a population.

Authors:  B Pepper; M C Kirshner; H Ryglewicz
Journal:  Hosp Community Psychiatry       Date:  1981-07

Review 9.  Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital.

Authors:  S F Greenfield; R D Weiss; M Tohen
Journal:  Community Ment Health J       Date:  1995-06

Review 10.  Detection of substance use disorders in severely mentally ill patients.

Authors:  R E Drake; A I Alterman; S R Rosenberg
Journal:  Community Ment Health J       Date:  1993-04
View more
  4 in total

1.  Measuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measures.

Authors:  K B Carey; S A Maisto; M P Carey; D M Purnine
Journal:  J Stud Alcohol       Date:  2001-01

Review 2.  Access to treatment for adolescents with substance use and co-occurring disorders: challenges and opportunities.

Authors:  Stacy Sterling; Constance Weisner; Agatha Hinman; Sujaya Parthasarathy
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-05-08       Impact factor: 8.829

3.  Management of "dual diagnosis" patients : consensus, controversies and considerations.

Authors:  D Basu; N Gupta
Journal:  Indian J Psychiatry       Date:  2000-01       Impact factor: 1.759

Review 4.  Integrating care for people with co-occurring alcohol and other drug, medical, and mental health conditions.

Authors:  Stacy Sterling; Felicia Chi; Agatha Hinman
Journal:  Alcohol Res Health       Date:  2011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.